14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
ECX vs LICN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, ECARX Holdings Inc. Class A (ECX) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECX carries a Unified Composite Score of 52.4/100 (HOLD) at $0.69 (12.1x Forward P/E, -4.6% operating margin), whereas LICN carries 45.6/100 (HOLD) at $0.01 (N/M Forward P/E, -87.1% operating margin).
Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile LICN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 15.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECX vs LICN. Trailing 12-month operating profitability (ECX -4.6% vs LICN -87.1%) and valuation multiples (ECX 12.1x vs LICN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Business Services value chain with $524,315 market capitalization and -87.1% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ECX vs LICN Key Questions & Quantitative Answers
As of Nov 19, 2026, ECARX Holdings Inc. Class A (ECX) is the stronger overall head-to-head candidate over Lichen China Limited Class A (LICN) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECX carries a Unified Composite Score of 52.4/100 (HOLD) at $0.69 (12.1x Forward P/E, -4.6% operating margin), whereas LICN carries 45.6/100 (HOLD) at $0.01 (N/M Forward P/E, -87.1% operating margin). Technical & Structure Timing Caution: ECX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile LICN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 15.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ECX leads the Growth & Scale pillar: ECX posts +9.5% YoY revenue growth and +0.0% YoY earnings growth on $902M TTM revenue (15.3% gross margin, -4.6% operating margin), compared with LICN at -28.0% YoY revenue growth and -51.3% YoY earnings growth on $21M TTM revenue (31.3% gross margin, -87.1% operating margin). On trailing 12-month operating scale, ECX generates $902M in USD-normalized revenue versus $21M for LICN. In operating R&D and SG&A reinvestment, ECX deploys 19.9% of Rev ($180M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LICN.
ECX screens cheaper on headline valuation multiples. ECX trades at 12.1x Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-2.4% EBITDA margin), whereas LICN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-80.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECX (-2237.6% ROE) versus LICN (-38.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ECX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.44β · 122% Vol realized risk). By comparison, LICN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.11β · 330% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.